{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:25:26Z","timestamp":1789683926980,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373367"],"award-info":[{"award-number":["82373367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Medical Science and Technology Research Foundation"},{"name":"Zhuhai science and technology plan project in the field of social development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC), the most aggressive breast cancer subtype, is characterised by poor prognosis and frequent lymph node metastasis (LNM), a hallmark of disease progression. Crosstalk between TNBC cells and M2-polarized macrophages drives malignant progression, but the specific mechanisms underlying M2 macrophage-mediated LNM in TNBC remain poorly defined. This study revealed that M2 macrophage-derived TGF-\u03b2 increases glycolysis and lymphatic metastasis in TNBC via a PKM2-centred axis. TGF-\u03b2 dually regulates PKM2 by transcriptionally upregulating its expression and posttranslational phosphorylation. This dual regulation drives PKM2-mediated metabolic reprogramming to increase tumour glucose uptake while promoting the nuclear translocation of p-PKM2, which transcriptionally activates the lymphatic growth factors VEGFC\/D. VEGFC\/D subsequently stimulates VEGF-dependent lymphangiogenesis, accelerating metastasis. Pharmacological PKM2 inhibition blocked PKM2 phosphorylation\/nuclear translocation and suppressed VEGFC\/D expression, thereby attenuating LNM. Clinically, high M2 macrophage infiltration correlated with a shorter disease-free survival and overall survival, paralleling prognostic trends in cohorts stratified by PKM2, VEGFC\/D, or lymphatic density levels. Serum analysis in an independent TNBC cohort confirmed elevated TGF-\u03b2 levels in LNM-positive versus LNM-negative patients. Our findings identify PKM2 as a driver of M2 macrophage-induced VEGFC\/D overexpression and lymphatic metastasis, highlighting its therapeutic potential for TNBC patients with high LNM risk.<\/jats:p>","DOI":"10.1038\/s41419-026-08524-4","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:39:44Z","timestamp":1772037584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["M2 macrophages promote lymphatic metastasis by regulating PKM2 nuclear translocation in triple-negative breast cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Yuqin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoshi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0656-1171","authenticated-orcid":false,"given":"Wenjing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-1773","authenticated-orcid":false,"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-3022","authenticated-orcid":false,"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"8524_CR1","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","volume":"23","author":"JD Brenton","year":"2005","unstructured":"Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol. 2005;23:7350\u201360.","journal-title":"J Clin Oncol"},{"key":"8524_CR2","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334.","journal-title":"Clin Cancer Res"},{"key":"8524_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938\u201348.","journal-title":"N Engl J Med"},{"key":"8524_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000336539","volume":"7","author":"L Zhang","year":"2012","unstructured":"Zhang L, Hao C, Dong G, Tong Z. Analysis of clinical features and outcome of 356 triple-negative breast cancer patients in China. Breast Care. 2012;7:13\u20137.","journal-title":"Breast Care"},{"key":"8524_CR5","doi-asserted-by":"crossref","unstructured":"Kulkarni A, Kelkar DA, Parikh N, Shashidhara LS, Koppiker CB, Kulkarni M. Meta-analysis of prevalence of triple-negative breast cancer and its clinical features at incidence in indian patients with breast cancer. JCO Glob Oncol. 2020;6:1052\u201362","DOI":"10.1200\/GO.20.00054"},{"key":"8524_CR6","doi-asserted-by":"crossref","unstructured":"Ji H, Hu C, Yang X, Liu Y, Ji G, Ge S, et al. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Ther. 2023;8:367.","DOI":"10.1038\/s41392-023-01576-4"},{"key":"8524_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1152\/physrev.00039.2021","volume":"102","author":"LC Dieterich","year":"2022","unstructured":"Dieterich LC, Tacconi C, Ducoli L, Detmar M. Lymphatic vessels in cancer. Physiol Rev. 2022;102:1837\u201379.","journal-title":"Physiol Rev"},{"key":"8524_CR8","doi-asserted-by":"crossref","unstructured":"Wu Z, Qu B, Yuan M, Liu J, Zhou C, Sun M, et al. CRIP1 reshapes the gastric cancer microenvironment to facilitate development of lymphatic metastasis. Adv Sci. 2023;10:e2303246.","DOI":"10.1002\/advs.202303246"},{"key":"8524_CR9","doi-asserted-by":"crossref","unstructured":"Mei X, Xiong J, Liu J, Huang A, Zhu D, Huang Y, et al. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4\/PI3K\/AKT axis and VEGF-C secretion. Cancer Lett. 2024;584:216609","DOI":"10.1016\/j.canlet.2024.216609"},{"key":"8524_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/0008-5472.CAN-23-2278","volume":"84","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chen J, Zheng H, Luo Y, An M, Lin Y, et al. SUMOylation-driven mRNA circularization enhances translation and promotes lymphatic metastasis of bladder cancer. Cancer Res. 2024;84:434\u201348.","journal-title":"Cancer Res"},{"key":"8524_CR11","doi-asserted-by":"crossref","unstructured":"Chen T, Ruan Y, Ji L, Cai J, Tong M, Xue Y, et al. S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE\/NF-kB\/VEGF-D pathway. Cancer Lett. 2024;587:216709","DOI":"10.1016\/j.canlet.2024.216709"},{"key":"8524_CR12","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.ymthe.2021.01.031","volume":"29","author":"J Zhu","year":"2021","unstructured":"Zhu J, Luo Y, Zhao Y, Kong Y, Zheng H, Li Y, et al. circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p\/TGFbetaR1\/VEGF-D signaling. Mol Ther. 2021;29:1838\u201352.","journal-title":"Mol Ther"},{"key":"8524_CR13","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1158\/0008-5472.CAN-18-3657","volume":"79","author":"C Tacconi","year":"2019","unstructured":"Tacconi C, Ungaro F, Correale C, Arena V, Massimino L, Detmar M, et al. Activation of the VEGFC\/VEGFR3 pathway induces tumor immune escape in colorectal cancer. Cancer Res. 2019;79:4196\u2013210.","journal-title":"Cancer Res"},{"key":"8524_CR14","doi-asserted-by":"crossref","unstructured":"Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8:207.","DOI":"10.1038\/s41392-023-01452-1"},{"key":"8524_CR15","doi-asserted-by":"crossref","unstructured":"Hoque MO, Zhang Q-w, Liu L, Gong C-y, Shi H-s, Zeng Y-h, et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE. 2012;7:e50946.","DOI":"10.1371\/journal.pone.0050946"},{"key":"8524_CR16","doi-asserted-by":"crossref","unstructured":"Zhu X, Liang R, Lan T, Ding D, Huang S, Shao J, et al. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. J ImmunoTher Cancer. 2022;10:e004219.","DOI":"10.1136\/jitc-2021-004219"},{"key":"8524_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.ymthe.2020.11.024","volume":"29","author":"Y Yang","year":"2021","unstructured":"Yang Y, Guo Z, Chen W, Wang X, Cao M, Han X, et al. M2 macrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2. Mol Ther. 2021;29:1226\u201338.","journal-title":"Mol Ther"},{"key":"8524_CR18","doi-asserted-by":"crossref","unstructured":"Wang W, Hu K, Xue J, Chen J, Du X, Zhao T, et al. In vivo FAP-CAR macrophages enhance chemotherapy and immunotherapy against pancreatic cancer by removing the fibrosis barrier. J Control Release. 2025;384:113888.","DOI":"10.1016\/j.jconrel.2025.113888"},{"key":"8524_CR19","doi-asserted-by":"crossref","unstructured":"Cai J, Zhang P, Cai Y, Zhu G, Chen S, Song L, et al. Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma. Adv Sci. 2025;12:e2413095.","DOI":"10.1002\/advs.202413095"},{"key":"8524_CR20","doi-asserted-by":"crossref","unstructured":"Zhang R, Shen Y, Zhang Q, Feng X, Liu X, Huo X, et al. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer. Cell Death Dis. 2023;14:850.","DOI":"10.1038\/s41419-023-06383-x"},{"key":"8524_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.7150\/ijbs.86085","volume":"20","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang L, Zhao L, Shao S, Ning Q, Jing X, et al. VEGFA\/NRP-1\/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk. Int J Biol Sci. 2024;20:446\u201363.","journal-title":"Int J Biol Sci"},{"key":"8524_CR22","doi-asserted-by":"crossref","unstructured":"Li H, Yang P, Wang J, Zhang J, Ma Q, Jiang Y, et al. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol. 2022;15:2.","DOI":"10.1186\/s13045-021-01223-x"},{"key":"8524_CR23","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1158\/0008-5472.CAN-23-3429","volume":"84","author":"J Xia","year":"2024","unstructured":"Xia J, Zhang L, Peng X, Tu J, Li S, He X, et al. IL1R2 blockade alleviates immunosuppression and potentiates anti-PD-1 efficacy in triple-negative breast cancer. Cancer Res. 2024;84:2282\u201396.","journal-title":"Cancer Res"},{"key":"8524_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/modpathol.2011.4","volume":"24","author":"RAA Mohammed","year":"2011","unstructured":"Mohammed RAA, Ellis IO, Mahmmod AM, Hawkes EC, Green AR, Rakha EA, et al. Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance. Mod Pathol. 2011;24:774\u201385.","journal-title":"Mod Pathol"},{"key":"8524_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","volume":"503","author":"S Zhu","year":"2021","unstructured":"Zhu S, Guo Y, Zhang X, Liu H, Yin M, Chen X, et al. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Cancer Lett. 2021;503:240\u20138.","journal-title":"Cancer Lett"},{"key":"8524_CR26","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","volume":"14","author":"W Yang","year":"2012","unstructured":"Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, et al. ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 2012;14:1295\u2013304.","journal-title":"Nat Cell Biol"},{"key":"8524_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1470-2045(24)00385-1","volume":"25","author":"AV Barrio","year":"2024","unstructured":"Barrio AV. Time to abandon axillary lymph node dissection in early-stage breast cancer. Lancet Oncol. 2024;25:1111\u20133.","journal-title":"Lancet Oncol"},{"key":"8524_CR28","doi-asserted-by":"crossref","unstructured":"Leon-Ferre RA, Goetz MP. Advances in systemic therapies for triple-negative breast cancer. BMJ. 2023;381:e071674","DOI":"10.1136\/bmj-2022-071674"},{"key":"8524_CR29","doi-asserted-by":"crossref","unstructured":"Lee CM, Hwang Y, Jeong JW, Kim M, Lee J, Bae SJ, et al. BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer. Cell Death Discov. 2024;10:5.","DOI":"10.1038\/s41420-023-01768-5"},{"key":"8524_CR30","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41388-018-0592-6","volume":"38","author":"R Kolb","year":"2018","unstructured":"Kolb R, Kluz P, Tan ZW, Borcherding N, Bormann N, Vishwakarma A, et al. Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene. 2018;38:2351\u201363.","journal-title":"Oncogene"},{"key":"8524_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41568-024-00681-y","volume":"24","author":"T Karakousi","year":"2024","unstructured":"Karakousi T, Mudianto T, Lund AW. Lymphatic vessels in the age of cancer immunotherapy. Nat Rev Cancer. 2024;24:363\u201381.","journal-title":"Nat Rev Cancer"},{"key":"8524_CR32","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1126\/science.10731318","volume":"296","author":"JE Gershenwald","year":"2002","unstructured":"Gershenwald JE, Fidler IJ. Targeting lymphatic metastasis. Science. 2002;296:1811\u20132.","journal-title":"Science"},{"key":"8524_CR33","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","volume":"70","author":"M Cadamuro","year":"2019","unstructured":"Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, et al. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. J Hepatol. 2019;70:700\u20139.","journal-title":"J Hepatol"},{"key":"8524_CR34","doi-asserted-by":"crossref","unstructured":"Dumond A, Montemagno C, Vial V, Gr\u00e9pin R, Pag\u00e8s G. Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas. Cells. 2021;10:1222.","DOI":"10.3390\/cells10051222"},{"key":"8524_CR35","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.7150\/jca.38981","volume":"11","author":"H Hu","year":"2020","unstructured":"Hu H, Tu W, Chen Y, Zhu M, Jin H, Huang T, et al. The combination of PKM2 overexpression and M2 macrophages infiltration confers a poor prognosis for PDAC patients. J Cancer. 2020;11:2022\u201331.","journal-title":"J Cancer"},{"key":"8524_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","volume":"182","author":"G Oliver","year":"2020","unstructured":"Oliver G, Kipnis J, Randolph GJ, Harvey NL. The lymphatic vasculature in the 21st Century: novel functional roles in homeostasis and disease. Cell. 2020;182:270\u201396.","journal-title":"Cell"},{"key":"8524_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.semcancer.2022.03.011","volume":"86","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cao Y. The impact of VEGF on cancer metastasis and systemic disease. Semin Cancer Biol. 2022;86:251\u201361.","journal-title":"Semin Cancer Biol"},{"key":"8524_CR38","doi-asserted-by":"crossref","unstructured":"Kong Y, Li Y, Luo Y, Zhu J, Zheng H, Gao B, et al. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p\/PIK3R1\/VEGF-C axis in pancreatic cancer. Mol Cancer. 2020;19:82.","DOI":"10.1186\/s12943-020-01205-6"},{"key":"8524_CR39","doi-asserted-by":"crossref","unstructured":"Wang M, Li Y, Xiao Y, Yang M, Chen J, Jian Y, et al. Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer. Nat Commun. 2021;12:7006.","DOI":"10.1038\/s41467-021-27348-8"},{"key":"8524_CR40","doi-asserted-by":"crossref","unstructured":"Zhang F, Yan Y, Cao X, Guo C, Wang K. Lv STGF-\u03b2-driven LIF expression influences neutrophil extracellular traps (NETs) and contributes to peritoneal metastasis in gastric cancer. Cell Death Dis. 2024;15:218.","DOI":"10.1038\/s41419-024-06594-w"},{"key":"8524_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2019.02.044","volume":"452","author":"X Tang","year":"2019","unstructured":"Tang X, Tu G, Yang G, Wang X, Kang L, Yang L, et al. Autocrine TGF-\u03b21\/miR-200s\/miR-221\/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation. Cancer Lett. 2019;452:79\u201389.","journal-title":"Cancer Lett"},{"key":"8524_CR42","doi-asserted-by":"crossref","unstructured":"de Streel G, Bertrand C, Chalon N, Li\u00e9nart S, Bricard O, Lecomte S, et al. Selective inhibition of TGF-\u03b21 produced by GARP-expressing Tregs overcomes resistance to PD-1\/PD-L1 blockade in cancer. Nat Commun. 2020;11:4545.","DOI":"10.1038\/s41467-020-17811-3"},{"key":"8524_CR43","doi-asserted-by":"crossref","unstructured":"Zhang Z, Deng X, Liu Y, Liu Y, Sun L, Chen F. PKM2, function and expression and regulation. Cell Biosci. 2019;9:52","DOI":"10.1186\/s13578-019-0317-8"},{"key":"8524_CR44","doi-asserted-by":"crossref","unstructured":"Zhao G, Yuan H, Li Q, Zhang J, Guo Y, Feng T, et al. DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. Signal Transduct Target Ther. 2022;7:275.","DOI":"10.1038\/s41392-022-01096-7"},{"key":"8524_CR45","doi-asserted-by":"crossref","unstructured":"Gao L, Yang F, Tang D, Xu Z, Tang Y, Yang D, et al. Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development. J Exp Clin Cancer Res. 2023;42:1.","DOI":"10.1186\/s13046-022-02574-0"},{"key":"8524_CR46","doi-asserted-by":"crossref","unstructured":"Zhang J, Ouyang F, Gao A, Zeng T, Li M, Li H, et al. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. Mol Cancer. 2024;23:94.","DOI":"10.1186\/s12943-024-02009-8"},{"key":"8524_CR47","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1016\/j.apsb.2024.04.024","volume":"14","author":"C Peng","year":"2024","unstructured":"Peng C, Yang P, Zhang D, Jin C, Peng W, Wang T, et al. KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2. Acta Pharm Sin B. 2024;14:2959\u201376.","journal-title":"Acta Pharm Sin B"},{"key":"8524_CR48","doi-asserted-by":"crossref","unstructured":"Hsu M-C, Hung W-C. Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling. Mol Cancer. 2018;17:35.","DOI":"10.1186\/s12943-018-0791-3"},{"key":"8524_CR49","doi-asserted-by":"crossref","unstructured":"Chen T-J, Wu C-H, Hung M-C, Wang W-C, Kung H-J. Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator. J Biomed Sci. 2025;32:75.","DOI":"10.1186\/s12929-025-01170-6"},{"key":"8524_CR50","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53:D1670\u2013D6.","journal-title":"Nucleic Acids Res"},{"key":"8524_CR51","doi-asserted-by":"crossref","unstructured":"Tian W, Yang Y, Qin Q, Zhang L, Wang Z, Su L, et al. Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer. Cancer Sci. 2022;114:619-629.","DOI":"10.1111\/cas.15610"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08524-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08524-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08524-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:12:35Z","timestamp":1773486755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08524-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8524"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08524-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted with the approval of the Ethics Committee of The Fifth Affiliated Hospital of Sun Yat-Sen University. Animal experiments were approved by the Institutional Animal Care and Use Committee of Beihua University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"262"}}